<DOC>
	<DOC>NCT00065650</DOC>
	<brief_summary>The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.</brief_summary>
	<brief_title>Pilot Study of Vedic Medicine for Type 2 Diabetes</brief_title>
	<detailed_description>Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Inclusion criteria: Kaiser Permanente members Newly diagnosed type 2 Diabetes Baseline glycosylated hemoglobin level of 6.07.9. Exclusion criteria: Pregnancy or nursing mother Currently taking warfarin Diagnosis of psychotic disorder or recent hospitalization for depression Unable to comply with or attend treatment sessions</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Diabetes Mellitus Type 2</keyword>
	<keyword>Vedic medicine</keyword>
	<keyword>Ayurveda</keyword>
	<keyword>Transcendental Meditation</keyword>
</DOC>